
Congruence Therapeutics Announces Participation In The 24Th Annual Needham Virtual Healthcare Conference
(MENAFN- PR Newswire) MONTREAL, March 26, 2025 /PRNewswire/ -- Congruence Therapeutics, a computationally-driven biotechnology company building a unique pipeline of correctors for diseases of protein misfolding, including MC4R-deficient genetic …